iVision Tech S.p.A.

BIT:IVN Stock Report

Market Cap: €17.2m

iVision Tech Past Earnings Performance

Past criteria checks 2/6

iVision Tech's earnings have been declining at an average annual rate of -44.8%, while the Medical Equipment industry saw earnings declining at 16.5% annually. Revenues have been growing at an average rate of 77.9% per year. iVision Tech's return on equity is 0.9%, and it has net margins of 0.4%.

Key information

-44.83%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.28%
Revenue growth rate77.85%
Return on equity0.93%
Net Margin0.45%
Last Earnings Update30 Jun 2025

Recent past performance updates

No updates

Recent updates

Estimating The Intrinsic Value Of iVision Tech S.p.A. (BIT:IVN)

Mar 28
Estimating The Intrinsic Value Of iVision Tech S.p.A. (BIT:IVN)

iVision Tech (BIT:IVN) Shareholders Will Want The ROCE Trajectory To Continue

Feb 01
iVision Tech (BIT:IVN) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of iVision Tech S.p.A. (BIT:IVN)

May 28
Estimating The Intrinsic Value Of iVision Tech S.p.A. (BIT:IVN)

Revenue & Expenses Breakdown

How iVision Tech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BIT:IVN Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2521080
31 Mar 2519070
31 Dec 2417070
30 Sep 2415060
30 Jun 2412050
31 Mar 2412050
31 Dec 2311040
30 Jun 2311140
31 Mar 2310040
31 Dec 229040
31 Dec 215030

Quality Earnings: IVN has high quality earnings.

Growing Profit Margin: IVN became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IVN's earnings have declined by 44.8% per year over the past 5 years.

Accelerating Growth: IVN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IVN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.2%).


Return on Equity

High ROE: IVN's Return on Equity (0.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/12 04:29
End of Day Share Price 2025/10/10 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iVision Tech S.p.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mattia PetraccaIntegrae SPA